Mr. Jackson Moves to Town: Overcoming Challenges to Optimizing RAASi Therapy

View this accredited e-learning program with a focus on heart failure at our partner website ReachMD, a leading online learning platform for physicians and other healthcare professionals

Heart failure is a global pandemic reported to affect at least 26 million people worldwide. Maximizing the inhibition of the renin-angiotensin-aldosterone system (RAAS) using optimally tolerated doses of inhibitors improves outcomes and reduces both morbidity and mortality associated with heart failure with reduced ejection fraction (HFrEF).

This case-based simulation will explore appropriate screening and monitoring strategies for patients with HFrEF as well as how to apply evidence-based approaches for maximizing guideline-recommended RAAS inhibitor therapies while managing potassium levels.

Educational information

Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

• Javed Butler, MD, MPH, MBAI, Professor and Chair, Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA

Disclosures

This activity is supported by an independent educational grant from Vifor Pharma.

View elearning at ReachMD